adalimumab

Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet
TNF inhibitors for psoriasis
by Jessica Kalen, MD on
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi …
Journal Review Series: April-June 2019
Journal Review Series
by ANNA H. CHACON, MD on
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019. It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat …
Anti-TNF-Induced Psoriasis in a Pyoderma Gangrenosum Patient
by NEXT STEPS IN DERM TEAM on
JDD authors Atrin Toussi BS BA, Stephanie T. Le MD,  Virgina R. Barton MD, Chelsea Ma MD,  Michelle Y. Cheng MD, Andrea Sukhov MD, Reason Wilken MD, Forum Patel MD, Elizabeth Wang MD,  and Emanual Maverakis MD present a case of a 60-year-old woman with recalcitrant pyoderma gangrenosum treated with adalimumab, who paradoxically developed psoriasis.  Introduction Pyoderma gangrenosum (PG) is …
Psoriasis in Skin of Color: Pearls from the Expert
Psoriasis in Skin of Color
by Lola Adekunle, MD on
As a first-year dermatology resident, I really enjoyed Dr. Andrew Alexis’ lecture on Psoriasis: Distinct Clinical Features and Treatment Options for Psoriasis Patients of Color at the Skin of Color Update. His lecture largely focused on the fundamentals of dermatology. He emphasized the importance of looking at color and distribution of the clinical presentation and recognizing common mimickers …